BlackRock ESG Capital Allocation Term Trust Issues Definitive Proxy for Contested Board Election Against Activist Saba Capital
ECAT is trading near its 52-week low of $13.35 (1.7% above the low) on elevated volume (2.0× avg).
Summary
BlackRock ESG Capital Allocation Term Trust has filed its definitive proxy statement, detailing a heated board election contest with activist investor Saba Capital Management, which seeks to replace a majority of the board.
Key Events · Corporate Governance and Compliance · ECAT
-
Definitive Proxy Statement Filed
The Trust issued its definitive proxy statement (DEFC14A) for its annual meeting on June 9, 2026, to elect trustees.
-
Contested Board Election
The incumbent Board is actively campaigning against activist investor Saba Capital Management, which has nominated eight individuals for election to the nine-member Board.
-
Activist Seeks Control
Saba Capital Management, holding 22.57% of outstanding shares, aims to elect its nominees, which the Board warns could lead to fundamental changes in management and strategy, including discontinuing discount management tools and potentially replacing the investment adviser.
-
Board's Defense
The current Board highlights the Trust's strong performance (86% return, 22% distribution rate, -3% discount to NAV) and shareholder-friendly initiatives as reasons to re-elect its nominees.
Analysis · ECAT · Unknown
This definitive proxy statement formalizes the ongoing proxy contest between BlackRock ESG Capital Allocation Term Trust's incumbent board and activist investor Saba Capital Management. Saba, which owns 22.57% of the outstanding shares, is seeking to elect eight nominees, potentially gaining near-total control of the nine-member board. The incumbent board strongly opposes Saba's nominees, arguing that they lack experience with the Trust and could discontinue shareholder-friendly initiatives like the discount management program and high distribution rate, and even replace the investment adviser. The Trust is incurring significant costs, estimated at $1.78 million, for proxy solicitation to defend its current board. This contest represents a critical battle for the Trust's strategic direction and governance, with potential implications for its investment objectives and shareholder value, especially as the stock trades near its 52-week low.
At the time of this filing, ECAT was trading at $13.58 on NYSE in the Unknown sector. The 52-week trading range was $13.35 to $17.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.